Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuronetics (STIM) Shares Issued (2017 - 2025)

Neuronetics (STIM) has disclosed Shares Issued for 8 consecutive years, with $4000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Shares Issued changed N/A to $4000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $618000.0, a N/A change, with the full-year FY2024 number at $2.5 million, up 252000.0% from a year prior.
  • Shares Issued was $4000.0 for Q3 2025 at Neuronetics, up from $1000.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $79.4 million in Q2 2021 to a low of -$78.5 million in Q4 2021.
  • A 4-year average of $335100.0 and a median of $26000.0 in 2022 define the central range for Shares Issued.
  • Biggest YoY gain for Shares Issued was 165275.0% in 2021; the steepest drop was 50444.23% in 2021.
  • Neuronetics' Shares Issued stood at -$78.5 million in 2021, then soared by 100.31% to $246000.0 in 2022, then skyrocketed by 145.93% to $605000.0 in 2024, then crashed by 99.34% to $4000.0 in 2025.
  • Per Business Quant, the three most recent readings for STIM's Shares Issued are $4000.0 (Q3 2025), $1000.0 (Q2 2025), and $8000.0 (Q1 2025).